# Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

> **NCT01341743** · PHASE4 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 360 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Entecavir, Adefovir
- **DRUG:** Entecavir, Adefovir

## Key facts

- **NCT ID:** NCT01341743
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2013-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341743, "Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01341743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*